According to the findings of our systematic review meta-analysis, apart from lifestyle changes, metformin, a classic insulin sensitizer seems to lead to some benefits in children with NAFLD, especially those with obesity, by improving some metabolic syndrome individual parameters. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.